On ECHEMI
Home > Drugs > Preterm birth
Preterm birth
In 1935, the American Academy of Pediatrics proposed that any live birth with a weight of 2500g or less is considered premature. In the subsequent clinical application process, people realized that there can be a large difference between gestational age and actual fetal weight when fetal growth is restricted. Therefore, in 1961, the World Health Organization established a standard for gestational age for premature birth, defining births of those who gave birth at less than 37 weeks of gestation as premature, but did not set a lower limit. There is no unified definition of premature birth at home and abroad. At present, my country defines premature birth as births of 28 to less than 37 weeks of gestation, calculated from the first day of the last menstrual period. People divide premature births into three categories based on gestational age: 1. Extreme premature births occur between 20 and 28 weeks of gestation, accounting for 5%. 2. Early premature births occur at <32 weeks of gestation, accounting for 10%. 3. Premature births between 32 and 36 weeks of gestation are considered mild premature births, accounting for 85%. Some scholars further divide 32-36 weeks into two subgroups, calling premature births before 32-34 weeks moderate premature births, and premature births between 34 and 36 weeks mild premature births.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Pregnant women between 28 and 37 weeks of pregnancy
  • Related symptoms:

    Cervical dilatation Threatened premature labor Premature rupture of membranes Vaginal bleeding Stomach ache
  • Concurrent disease:

Related Drugs
Ambroxol Hydrochloride
Indication: It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as: acute exacerbation of chronic bronchitis, expectorant treatment of asthmatic bronchitis and bronchial asthma; preemptive treatment of postoperative pulmonary complications; treatment of premature infants and neonatal infant respiratory distress syndrome (IRDS).
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Ambroxol Hydrochloride
Indication: It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as: acute exacerbation of chronic bronchitis, expectorant treatment of asthmatic bronchitis and bronchial asthma; preemptive treatment of postoperative pulmonary complications; treatment of premature infants and neonatal infant respiratory distress syndrome (IRDS).
Manufacturer:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Ambroxol Hydrochloride
Indication: It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as: acute exacerbation of chronic bronchitis, expectorant treatment of asthmatic bronchitis and bronchial asthma; preemptive treatment of postoperative pulmonary complications; treatment of premature infants and neonatal infant respiratory distress syndrome (IRDS).
Manufacturer:

Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.

Ambroxol Hydrochloride
Indication: It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as: acute exacerbation of chronic bronchitis, expectorant treatment of asthmatic bronchitis and bronchial asthma; preemptive treatment of postoperative pulmonary complications; treatment of premature infants and neonatal infant respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride
Indication: It is suitable for acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as: acute exacerbation of chronic bronchitis, expectorant treatment of asthmatic bronchitis and bronchial asthma; preemptive treatment of postoperative pulmonary complications; treatment of premature infants and neonatal infant respiratory distress syndrome (IRDS).
Manufacturer:

Yangzhou NO.3 Pharmacitical Manufacture Co., Ltd.

Hexonaline Hydrochloride Tablets
Indication: It is used to relieve bronchospasm caused by bronchial asthma and chronic asthmatic bronchitis. It is also used to relieve fetal asphyxia and premature birth signs caused by excessive uterine contraction during delivery.
Manufacturer:

Beijing Wanhui Double-Crane Pharmaceutical Company Limited

Hexonaline Hydrochloride Tablets
Indication: It is used to relieve bronchospasm caused by bronchial asthma and chronic asthmatic bronchitis. It is also used to relieve fetal asphyxia and premature birth signs caused by excessive uterine contraction during delivery.
Manufacturer:

Hebei Ruisen Pharmaceutical Co., Ltd.

Hexonaline Hydrochloride Tablets
Indication: It is used to relieve bronchospasm caused by bronchial asthma and chronic asthmatic bronchitis. It is also used to relieve fetal asphyxia and premature birth signs caused by excessive uterine contraction during delivery.
Manufacturer:

Tonghua Yason Pharmaceuticals Co., Ltd.

Ambroxol Hydrochloride Injection
Indication: 1. Applicable to acute and chronic lung diseases accompanied by abnormal sputum secretion and poor expectoration function. For example, acute exacerbation of chronic bronchitis, asthmatic bronchitis and expectoration treatment of bronchial asthma. Preventive treatment of postoperative pulmonary complications. 2. Treatment of infant respiratory distress syndrome (IRDS) in premature infants and newborns.
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Ambroxol Hydrochloride Injection
Indication: 1. Applicable to acute and chronic lung diseases accompanied by abnormal sputum secretion and poor expectoration function. For example, acute exacerbation of chronic bronchitis, asthmatic bronchitis and expectoration treatment of bronchial asthma. Preventive treatment of postoperative pulmonary complications. 2. Treatment of infant respiratory distress syndrome (IRDS) in premature infants and newborns.
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.